Effect of zinc supplementation on insulin resistance and components of the metabolic syndrome in prepubertal obese children
Zinc, an essential trace element and a component of many enzymes, is involved in the synthesis, storage and release of insulin. The aim of the present study was to assess the effect of zinc supplementation on insulin resistance and components of the metabolic syndrome in prepubertal obese children.
This triple-masked, randomized, placebo-controlled cross-over trial was conducted among 60 obese Iranian children in 2008. Pertinent clinical findings, fasting serum glucose, insulin and lipid profile were assessed. Participants were randomly assigned to two groups of equal number; one group received 20mg elemental zinc and the other group received placebo on a regular daily basis for eight weeks. After a 4-week wash-out period, the groups were crossed over.
The mean age of participants was 9.1 ± 1.1 years. After receiving zinc, the mean fasting plasma glucose (FPG), insulin and HOMA-IR decreased significantly, while body mass index (BMI), waist circumference (WC), LDL-C and triglycerides (TG) did not significantly change. After receiving placebo, the mean FPG, insulin and HOMA-IR increased significantly, while BMI, WC, LDL-C and TG showed a non-significant increase.
Besides lifestyle modification, zinc supplementation might be considered as a useful and safe additional intervention treatment for improvement of cardiometabolic risk factors related to childhood obesity.
KeywordsCardiometabolic risk factors Childhood obesity Metabolic Syndrome Pre-pubertal stage Zinc
- 3.Steinberger J, Daniels SR, Eckel RH, et al, 2009 American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 119: 628–647.CrossRefGoogle Scholar
- 10.Lee K, Lee J, Bae WK, Choi JK, Kim HJ, Cho B, 2009 Efficacy of low-calorie, partial meal replacement diet plans on weight and abdominal fat in obese subjects with metabolic syndrome: a double-blind, randomised controlled trial of two diet plans — one high in protein and one nutritionally balanced. Int J Clin Pract 63: 195–201.CrossRefGoogle Scholar
- 12.Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, 2000 CDC growth charts: United States. Adv Data 314: 1–27.Google Scholar
- 17.http://www.springboard4health.com/notebook/min_zinc.html, accessed 8.8.2009Google Scholar
- 20.Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R, 2009 The First Nationwide Study of the Prevalence of the Metabolic Syndrome and Optimal Cut-off Points of Waist Circumference in the Middle East: The National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care 32: 1092–1097CrossRefGoogle Scholar